Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-4 (Clone 11B11)
Applications | ELISA, FC, IHC |
Reactivities | Mouse |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-4 (Clone 11B11)
Applications | ELISA, FC, IHC |
Reactivities | Mouse |
Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
Applications | ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-VAP-1 (Clone TK8-14)
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-VAP-1 (Clone TK8-14)
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VAP-1 (Clone 2D10)
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-VAP-1 (Clone 2D10)
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IFN gamma (Clone D9D10)
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IFN gamma (Clone D9D10)
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-MUC1 (Clone SM3)
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone SM3)
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
Applications | ELISA, FC, IF, IHC, WB |
Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
Conjugation | Unconjugated |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
Applications | ELISA, FC, IF, IHC, WB |
Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone 13B8.2)
Applications | EIA, ELISA, FC, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
Applications | EIA, ELISA, FC, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IgM (Clone M15/8)
Applications | ELISA, FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IgM (Clone M15/8)
Applications | ELISA, FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VEGF (Clone A.4.6.1)
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human, Rat |
Conjugation | Unconjugated |
Recombinant Anti-C3a-receptor (Clone 3G7)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-C3a-receptor (Clone 3G7)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-NgR1 (Clone M5)
Applications | ELISA, FC, IP, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Recombinant Anti-NgR2 (Clone P14)
Applications | ELISA, FC, IP, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-SIRP- beta & gamma (Clone OX117)
Applications | ELISA, FC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-SIRP- beta & gamma (Clone OX117)
Applications | ELISA, FC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | ELISA, FC, IHC |
Reactivities | Chimpanzee, Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | ELISA, FC, IHC |
Reactivities | Chimpanzee, Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | ELISA, FC, IHC |
Reactivities | Chimpanzee, Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD28 (Clone 1C6)
Applications | Bl, ELISA, FC |
Reactivities | Dog |
Conjugation | Unconjugated |
Recombinant Anti-Integrin α-M (Clone 107)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD30 (Clone Ki-3)
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD30 (Clone Ki-3)
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |